Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
9 pending office actions • 7 clients • 9 examiners • 6 art units • 0 of 9 (0%) have an AI response strategy ready • 29 patents granted in the last 365 days
EAGLE IP LIMITED has managed 678 career applications, with a primary focus on the Biotechnology & Pharmaceuticals technology area. The firm maintains a resolved allowance rate of 88.91 percent for its clients. This outcome is further evidenced by an average of 2.25 office actions per allowance, which describes the prosecution process required to reach these grants.
The firm currently has 7 pending office actions under management. These active matters are handled within the context of the firm's broader experience with 678 total applications. The 88.91 percent allowance rate and the 2.25 average office actions per allowance provide a data set for evaluating the firm's performance in the life sciences sector. Practitioners can observe the probability of allowance and the procedural steps based on these historical metrics. With 7 pending actions, the firm continues its work in biotechnology following its career history.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 1 (11%) |
| §103 only | 3 (33%) |
| §112 only | 1 (11%) |
| Double-patenting + other | 1 (11%) |
| Multi-statute (no §101) | 3 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| TRAN, UYEN M | 1 | 31.2% | +39.2% |
| JONES, CHRISTOPHER P | 1 | 76.1% | +24.8% |
| KUNEMUND, ROBERT M | 1 | 82.0% | +13.2% |
| LAU, JONATHAN S | 1 | 63.7% | -17.3% |
| MARTIN, PAUL C | 1 | 41.8% | +21.6% |
| KATAKAM, SUDHAKAR | 1 | 74.7% | +23.3% |
| VANN-OJUEKAIYE, KENDRA RAYCHELL | 1 | 0.0% | +0.0% |
| MPAMUGO, CHINYERE | 1 | 28.5% | +26.9% |
| CREWS, JARET JAMES | 1 | 44.7% | +70.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18350726 | Metadata-Based Diagnosis and Management System for Cardiovascular and Cerebrovascular Diseases | MPAMUGO, CHINYERE | 155d overdue |
| 19539091 | CONDUCTIVE, MULTILAYER STACKS FOR USE IN SILICON SOLAR CELLS AND PROCESSES FOR MAKING AND USING THE SAME INCLUDING LASER-BASED PROCESSES | TRAN, UYEN M | — |
| 18710633 | USES OF SPINEL-TYPE SINGLE CRYSTALS AS FERROELECTRICS AND RELAXOR FERROELECTRICS, ENERGY STORAGE MATERIAL AND RECHARGEABLE ENERGY STORAGE PRODUCT | KUNEMUND, ROBERT M | — |
| 18576751 | APPLICATION OF SPHERE SUBSTANCE IN PREPARATION OF INTRAVENOUS INJECTION | MARTIN, PAUL C | — |
| 18463312 | METHODS AND KITS FOR ISOLATING TARGET NUCLEIC ACIDS BELOW A TARGET SIZE FROM A SAMPLE | VANN-OJUEKAIYE, KENDRA RAYCHELL | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 7 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18350726 | Metadata-Based Diagnosis and Management System for Cardiovascular and Cerebrovascular Diseases | MPAMUGO, CHINYERE | 155d overdue |
| 17753178 | METHOD, COMPOSITION AND KIT FOR SIZE SELECTIVE ENRICHMENT OF NUCLEIC ACIDS | CREWS, JARET JAMES | 72d |
| 19539091 | CONDUCTIVE, MULTILAYER STACKS FOR USE IN SILICON SOLAR CELLS AND PROCESSES FOR MAKING AND USING THE SAME INCLUDING LASER-BASED PROCESSES | TRAN, UYEN M | — |
| 18817280 | Air Filter That Is Easy To Replace And Install | JONES, CHRISTOPHER P | — |
| 18710633 | USES OF SPINEL-TYPE SINGLE CRYSTALS AS FERROELECTRICS AND RELAXOR FERROELECTRICS, ENERGY STORAGE MATERIAL AND RECHARGEABLE ENERGY STORAGE PRODUCT | KUNEMUND, ROBERT M | — |
| 18576751 | APPLICATION OF SPHERE SUBSTANCE IN PREPARATION OF INTRAVENOUS INJECTION | MARTIN, PAUL C | — |
| 18399726 | ECHINOCANDIN-BASED DRUG, AND PREPARATION METHOD THEREFOR AND USE THEREOF | KATAKAM, SUDHAKAR | — |
| Art Unit | Apps |
|---|---|
| 1726 | 1 |
| 1714 | 1 |
| 1658 | 1 |
| 1682 | 1 |
| 3685 | 1 |
| 1691 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 19539091 | CONDUCTIVE, MULTILAYER STACKS FOR USE IN SILICON SOLAR CELLS AND PROCESSES FOR MAKING AND USING THE SAME INCLUDING LASER-BASED PROCESSES | Photara Inc. | TRAN, UYEN M | 1726 | §102§103 | Non-Final OA | — | Pending | Feb 13, 2026 |
| 18817280 | Air Filter That Is Easy To Replace And Install | Focus & Co., (Far East) Limited | JONES, CHRISTOPHER P | §103 | Non-Final OA | — | Pending | Aug 28, 2024 | |
| 18710633 | USES OF SPINEL-TYPE SINGLE CRYSTALS AS FERROELECTRICS AND RELAXOR FERROELECTRICS, ENERGY STORAGE MATERIAL AND RECHARGEABLE ENERGY STORAGE PRODUCT | UNIVERSITY OF MACAU | KUNEMUND, ROBERT M | 1714 | §102§103 | Final Rejection | — | Pending | May 16, 2024 |
| 18708217 | GLUCOHEXAOSE AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF, AND HAIR REGENERATION PREPARATION | UNIVERSITY OF MACAU | LAU, JONATHAN S | §112 | Non-Final OA | — | Pending | May 08, 2024 | |
| 18576751 | APPLICATION OF SPHERE SUBSTANCE IN PREPARATION OF INTRAVENOUS INJECTION | Yunnan Key Laboratory Of Primate Biomedical Research | MARTIN, PAUL C | §102§103§112 | Non-Final OA | — | Pending | Jan 05, 2024 | |
| 18399726 | ECHINOCANDIN-BASED DRUG, AND PREPARATION METHOD THEREFOR AND USE THEREOF | Shenzhen Sungening Biological Co., Ltd. | KATAKAM, SUDHAKAR | 1658 | §103 | Non-Final OA | — | Pending | Dec 29, 2023 |
| 18463312 | METHODS AND KITS FOR ISOLATING TARGET NUCLEIC ACIDS BELOW A TARGET SIZE FROM A SAMPLE | Phase Scientific International, Ltd. | VANN-OJUEKAIYE, KENDRA RAYCHELL | 1682 | §103§112DP | Final Rejection | — | Pending | Sep 08, 2023 |
| 18350726 | Metadata-Based Diagnosis and Management System for Cardiovascular and Cerebrovascular Diseases | Serv Medical Pte. Ltd. | MPAMUGO, CHINYERE | 3685 | §101 | Non-Final OA | 155d overdue | Pending | Jul 11, 2023 |
| 17753178 | METHOD, COMPOSITION AND KIT FOR SIZE SELECTIVE ENRICHMENT OF NUCLEIC ACIDS | Phase Scientific International, Ltd. | CREWS, JARET JAMES | 1691 | §103 | Non-Final OA | 72d | Pending | Feb 22, 2022 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial